Legal

General presentation
You are currently connected to the website www.nextep.fr which is published by Nextep.
Company name: Nextep
Address: 18/20 Place de la Madeleine - 75008 Paris - France.
Publication Director: Guillaume BOUCHARA
Tel.: +33 (0)1 53 38 44 50
SARL with a capital of: € 250,000 Siret: 421 468 018 00039
The publisher agrees to comply with all the laws pertaining to creating and running a website.
 
Technical information
The confidentiality of communications is not guaranteed over the Internet and it is the responsibility of each Internet user to take all appropriate measures to protect their own data and/or software from contamination by viruses that may be circulated over the Internet.
 
Hyperlinks
Creation of hyperlinks to the website www.nextep.fr is subject to prior approval by its Publication Director. Hypertext links pointing to other sites from www.nextep.fr may under no circumstances engage the responsibility of Nextep.
 
Personal data
The information that you enter will be sent to the various departments concerned to provide an appropriate response to your request. None of this information will be used by Nextep for sending commercial offers. You have the right to access, modify, correct and delete the data compiled on the website, under the conditions set out by the French law No. 78-17 of 6th January 1978 pertaining to information technology, data files and civil liberties. In order to exercise your right, send your letter to the website manager at the following address: Nextep - 18/20 Place de la Madeleine - 75008 Paris – France.
 
Editorial charter
The website www.nextep.fr is a site presenting the services offered by Nextep.
The information on this site is provided for information purposes only.
 
Copyright
The reproduction or representation, in whole or in part, of the pages, data and any other element making up the website, by whatever means or using whatever media is prohibited and constitutes infringement of copyright if done without the authorization of the publisher. Pharma Express and Pharma Express Jurisprudence are trademarks registered by Nextep.
 
Giving priority to company values, such as respect, ethics and confidentiality, Nextep is committed to fulfilling its missions with engagement, reactivity, rigor and transparency.
And so that these values do not remain solely concepts and ideas, our firm is concretely involved on a number of fronts in these fields:
Nextep has been a member of the French association of lobbying and public affairs consultancies (Association française des conseils en lobbying et affaires publiques - AFCL) since 2011 and a co-signatory to the AFCL charter (cf. www.afcl.net/deontologie ).
Operating in particular on behalf of many subsidiaries of American companies, especially in the field of market access for health care products, our firm is subject to and fully complies with the regulatory obligations under the Foreign Corrupt Practices Act (FCPA – cf. Lien vers Foreign Corrupt Practices Act), and the Sunshine Act (Lien vers Physician Payments Sunshine Act). The latter served as a basis for Bertrand's Act of 29 December 2011, in respect of which we assist our customers in the reporting formalities and obligations. (Transparence.sante.gouv)